SAMUEL BRADY: Open Payments
NPI 1174156699 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $1,162 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $156 |
| Amgen Inc. | 2 | $30 |
| Grifols USA, LLC | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Bimzelx, EVENITY, Prolastin-C Liquid, PURIFIED CORTROPHIN GEL, BENLYSTA, SKYRIZI, SAPHNELO.
Industry payments across CO — which companies pay providers there.
